# MIRACULINS INC: Form D filings

MIRACULINS INC, a biotechnology company in Winnipeg, Manitoba, Canada, filed 3 Form D notices with the SEC between 2013 and 2015. The latest, on May 1, 2015, reports $20,408 sold of a $51,019 offering to 1 investor.

Find out what MIRACULINS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20MIRACULINS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=MIRACULINS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fmiraculins-inc-1584322)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20MIRACULINS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=MIRACULINS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fmiraculins-inc-1584322)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 6-1250 WAVERLEY STREET, Winnipeg, Manitoba, Canada, R3T 6
- Phone: (204) 453-1408
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Canada (Federal Level)
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1584322

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 1, 2015 | New notice | $51,019 | $20,408 | $30,611 | 1 | Apr 22, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1584322/000118374015000091/0001183740-15-000091-index.htm) |
| Jan 5, 2015 | New notice | $215,025 | $0 | $215,025 | 1 | Dec 23, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1584322/000118374015000001/0001183740-15-000001-index.htm) |
| Aug 13, 2013 | New notice | $2,247,354 | $888,716 | $1,358,638 | 1 | Jul 31, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1584322/000118374013000306/0001183740-13-000306-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| L. MICHAEL COUTTS | Executive Officer |  |
| WILLIAM J.F. ROBERTS | Director |  |
| HARRY J.F. BLOOMFIELD | Director |  |
| JAMES J.F. KINLEY | Executive Officer |  |
| P. MARCUS J.F. ENNS | Executive Officer |  |
| MICHAEL J.F. EVELEGH | Executive Officer |  |
| PAUL J.F. MOREAU | Executive Officer |  |
| CHRISTOPHER J MOREAU | Executive Officer, Director |  |
| MICHAEL J.F. STASIUK | Director |  |

[Every Form D from the week of Apr 27, 2015](https://specstream.ai/data/form-d/week/2015-04-27) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what MIRACULINS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).